Impact of early response and CXCR4 mutation status on progression-free survival with ibrutinib-based therapy in Waldenstrom macroglobulinemia: a post hoc analysis of the iNNOVATE trial

Jorge Castillo,Shayna Sarosiek,Andrew Branagan, Alex Bokun, Hillary Peltier, Vincent Girardi, Michelle Pacia,Steven Treon

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览8

暂无评分

关键词

waldenström macroglobulinemia,cxcr4 mutation status,progression-free,ibrutinib-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要